Сумамед форте

Quick links

Choose a section

Quick links to important sections

Advertisements

Сумамед форте

Selected form

Advertisements
Advertisements

Overview of Сумамед форте

Quick Facts: Сумамед Форте Identity

Property Description
Active ingredient Azithromycin (as Dihydrate)
Form Powder for Oral Suspension
Pharmacological class Macrolide Antibiotic (Azalide subclass)
General purpose Containment and elimination of susceptible bacterial infections
Origin Synthetic (semi-synthetic derivative)

What Type of Medicine is Сумамед Форте? (Classification and Composition)

Сумамед форте is a prescription-only medication primarily used against a broad-spectrum of bacterial infections. Its foundation is the active compound Azithromycin Dihydrate, the International Nonproprietary Name (INN), which defines it as a synthetic, single-ingredient product. The medicine belongs to the Macrolide antibiotic family but is specifically designated an Azalide, a classification defined by the unique nine-membered ring structure of the azalide group. Azithromycin possesses an exceptionally long half-life and achieves high tissue penetration compared to older macrolides. This unique property means the drug is sustained in the body's tissues for a longer duration, providing prolonged antimicrobial activity for targeted therapies.

Сумамед Форте: Available Form and General Purpose

The Сумамед форте preparation is typically supplied as a powder for oral suspension, intended to be mixed with water to form a liquid. This specific oral form is a key differentiating feature, allowing for precise and easier administration, particularly for pediatric patients who may not be able to ingest solid forms. Azithromycin works by inhibiting bacterial protein synthesis. This mechanism ensures the medicine’s primary general purpose is to halt the growth and multiplication of pathogenic bacteria. The broad-spectrum action of Сумамед форте aids the body in overcoming illnesses, such as those affecting the respiratory tract, by containing the bacterial source.

Regulatory References

  1. MedlinePlus
Advertisements

What side effects are possible with Сумамед форте?

The safety profile for Azithromycin, the active component in Сумамед форте, is established by regulatory documents and organized by frequency and affected organ system.

Frequency-Classified Adverse Reactions

The most frequently documented effects relate to Gastrointestinal Disorders, which are often classified as Very Common (ge 1/10) in official regulatory documentation. These include diarrhea, abdominal pain, nausea, and flatulence.

Reactions classified as Common (ge 1/100, < 1/10) include vomiting, dyspepsia, headache, and dizziness. Effects like Torsades de Pointes (a type of arrhythmia) and hepatic failure are documented as serious events of Not Known frequency.


Documented Serious Systemic Risks

The medicine is associated with the potential for QT interval prolongation, which imparts a risk of developing serious cardiac arrhythmias. Regulatory warnings also highlight hepatotoxicity, with cases of severe, sometimes fatal, fulminant hepatitis and hepatic failure reported.

Severe, rare allergic reactions, including anaphylaxis and life-threatening skin conditions like Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN), are officially documented. The label also notes that severe allergic symptoms may recur even after initial successful treatment is discontinued.


Population-Specific Safety Considerations

Specific caution is mandated for patients with severe hepatic or renal impairment. Older adults are noted as potentially more susceptible to drug-associated effects on the QT interval. Furthermore, the regulatory label notes the potential for exacerbation of Myasthenia Gravis symptoms and reports of Infantile Hypertrophic Pyloric Stenosis (IHPS) in neonates/infants.

Advertisements

Overdose and Emergency Response

Azithromycin, the active ingredient in Сумамед форте, is generally associated with adverse reactions following an overdose that are extensions of common side effects. The primary symptoms experienced at higher than recommended doses are typically gastrointestinal in nature.

Potential Symptoms of Overdose

The most commonly reported symptoms of azithromycin overdose are similar to the side effects seen at normal therapeutic doses, but they may be more pronounced. These can include:

Symptom Category Examples of Symptoms
Gastrointestinal Severe nausea, vomiting, or diarrhea
Auditory Reversible hearing loss (reported at very high doses)

Serious, though less common, concerns with high-dose azithromycin, particularly in susceptible individuals, include the potential for heart rhythm disturbances, specifically QT interval prolongation, which can lead to life-threatening arrhythmias like torsades de pointes.

When to Seek Immediate Help

Always seek emergency medical attention or contact a poison control center immediately if you suspect an overdose of Сумамед форте, even if you do not feel any symptoms. Overdose management involves general symptomatic and supportive measures as required, and a healthcare professional will assess the patient for potential cardiac, liver, and other systemic toxicities.

Immediate medical help is mandatory if symptoms include:

  • Severe vomiting or persistent, watery diarrhea.
  • Signs of an irregular or fast heartbeat, dizziness, or fainting.
  • Any signs of a severe allergic reaction, such as swelling of the face, tongue, or throat, or difficulty breathing.
Advertisements

Therapeutic Uses of Сумамед форте

What Сумамед Форте Treats: Main Uses and Benefits

Сумамед форте is used for the management of bacterial infections. This application is relevant in clinical settings that involve acute or unstable symptom patterns in conditions marked by increased physiological stress. The medication contributes to easing the overall symptom load associated with these conditions.

The medicine is relevant within therapeutic areas involving heightened responses to manage infections such as bronchitis, pneumonia, sinusitis, pharyngitis, and middle ear infections. It is also applied in scenarios where additional management of discomfort is required for uncomplicated skin infections and specific Sexually Transmitted Infections.

“It is applied in contexts marked by increased discomfort or tension, helping to address symptom clusters that may become intense.”

This focused use supports the patient during difficult episodes by helping with symptom management and is helpful in situations requiring additional symptomatic assistance, particularly in pediatric patients and those with chronic respiratory conditions.

Quick Fact: Relief for Acute Discomfort
Symptom Focus: Addresses clusters of fever, pain, cough, and inflammation associated with bacterial presence.
Benefit Frame: Supports patient comfort and helps ease the overall symptom load during periods of heightened symptoms.

Regulatory References

  1. Azithromycin: MedlinePlus Drug Information
Advertisements

Eligibility and Restrictions for Use

Eligibility Profile: Who Can and Cannot Use

Сумамед форте (Azithromycin Oral Suspension) eligibility is strictly governed by regulatory documentation, based on patient history, age, and existing medical conditions.


Absolute Non-Eligibility (Contraindications)

The medicine is strictly contraindicated and must not be used by specific populations, including:

  • Patients with a known hypersensitivity or allergy to Azithromycin or any other macrolide or ketolide antibiotic.
  • Patients with a prior history of cholestatic jaundice or hepatic dysfunction linked to previous Azithromycin use.

Age and Condition-Based Restrictions

Use is generally established for adults and pediatric patients starting from six months of age and older. Use in infants under six months is typically not established. Older adults may require special caution due to potential risk of cardiac arrhythmia.

Conditional use is required, or the medicine is not recommended, for certain patient groups:

  • Patients with severe hepatic impairment or severe renal impairment.
  • Individuals with conditions that predispose to QT interval prolongation or Myasthenia Gravis.
  • Women who are pregnant or breastfeeding, where use is only permitted if the clinical benefit outweighs the potential risk.
Advertisements

What should I know about interactions with other medicines?

The official regulatory profile for Azithromycin (the active substance in Сумамед форте) is structured around documented pharmacodynamic risks, mandatory timing constraints, and pharmacokinetic changes in drug exposure.

Contraindicated and High-Risk Combinations

  • Ergot Derivatives: Co-administration with substances such as Ergotamine is formally contraindicated by regulatory agencies due to the theoretical potential for ergotism.
  • QT-Prolonging Agents: Concomitant use with medicinal products known to prolong the QT interval (e.g., Class IA and III Antiarrhythmics) imparts a documented pharmacodynamic risk of developing cardiac arrhythmia and Torsades de pointes.

Interactions Requiring Mandatory Monitoring

  • Oral Anticoagulants (Warfarin): Regulatory documents state that co-administration may potentiate the effects of oral anticoagulants, which requires mandatory monitoring of prothrombin time.
  • P-glycoprotein Substrates: Increased serum levels of P-gp substrates, such as Digoxin, may occur, necessitating serum concentration monitoring.
  • Nelfinavir: Co-administration results in increased Azithromycin serum concentrations (AUC and Cmax), a documented pharmacokinetic effect.

Administration and Population Constraints

  • Antacids: Aluminum- and Magnesium-containing Antacids reduce the drug's peak serum concentration (Cmax). Azithromycin must be administered at least 1 hour before or 2 hours after the antacid.
  • Population Note: Elderly patients are identified in regulatory labeling as having a potentially heightened risk of cardiac arrhythmia when co-administered with QT-prolonging drugs.
Advertisements

Mechanism of Action

How Сумамед форте Works: The Mechanism of Action


Molecular Inhibition of Protein Production

The fundamental mechanism involves the molecule binding directly to the bacterial 50S ribosomal subunit, specifically at the 23S ribosomal RNA component. This non-competitive interaction physically blocks the polypeptide exit tunnel, which consequently halts the elongation of essential protein chains. This cascade is the primary event that inhibits cellular growth and replication of susceptible foreign cells.


Targeted Tissue Delivery

The molecule exhibits high lipophilicity and is actively absorbed and concentrated within the body's own phagocytic immune cells (macrophages and neutrophils). These cells function as biological carriers, enabling targeted delivery and local release of the molecule directly at the sites of active tissue response, which results in elevated local concentrations of the molecule in affected tissues.


Regulation of Host Signaling

This domain addresses the molecule's ability to subtly modulate key signaling pathways (like NF-κB and MAPK) within human immune cells. This interaction reduces the synthesis of pro-inflammatory chemical messengers (e.g., cytokines and chemokines), leading to a decreased influx of inflammatory mediators at the site of response.

Advertisements

Dosage and Administration Information

Instruction Map: How to use Сумамед форте — Administration Guidelines


Administration Scope

Feature Instruction Summary
Route of administration Oral (Suspension, Tablets) and Intravenous (IV) (Infusion only)
Dosing schedule Standard adult regimens are 500 mg once daily for 3 days, or 500 mg on Day 1 followed by 250 mg once daily on Days 2–5. Single 1-gram doses are also documented.
Timing in relation to meals Oral forms can generally be taken with or without food. Intake must be separated from aluminum- or magnesium-containing antacids by at least one to two hours.
Preparation requirements The powder for oral suspension must be reconstituted with water and shaken before measuring the dose. Single-dose packets require specific mixing with water and a glass rinse to ensure the full dose is consumed.
Age-group administration rules Dosing for pediatric patients is calculated on a body weight basis (mg/kg) using the oral suspension form; tablets are unsuitable for children weighing less than 45 kg.
Missed-dose rules If a dose is missed, the instruction is to take the dose immediately upon remembering and then resume subsequent doses 24 hours after the last dose was taken. Doubling a dose is not permitted.
Special procedural conditions The IV form must be administered only as a slow intravenous infusion over a period of 1 to 3 hours; it is not approved for bolus or intramuscular injection.

Instruction Classifications (High-Level)

Classification Pattern
Administration method type Oral / Intravenous (IV Infusion)
Frequency pattern Once daily (qDay) or Single dose
Use-context constraints Weight-based dosing for pediatric population; mandatory separation from antacids; restricted to slow IV infusion for the intravenous route.

Resulting Procedural Structure

Step sequence:

  • The oral suspension is reconstituted with water and shaken before measuring.
  • The medicine is taken once daily according to the 3-day or 5-day standardized schedule.
  • If a daily dose is missed, it must be taken immediately, with the remaining schedule adjusted to maintain 24-hour intervals.

Connection to the overall use protocol (2–4 sentences): The protocol is centered on once-daily administration across defined short-course durations to leverage the drug's long half-life. The protocol involves weight-based dosing with the oral suspension for smaller children and explicitly restricts the IV administration to a slow infusion. Furthermore, instructions specify preparation steps for the powder and require separation from antacids to ensure proper intake and absorption.

Advertisements

Recent Clinical Evidence

Recent Clinical Evidence for Azithromycin

Сумамед форте contains the active substance azithromycin, a macrolide antibiotic with a long tissue half-life that allows for shorter treatment durations compared to many other antibiotics. Recent clinical research efforts have focused on optimizing its use and understanding its role in complex patient populations.

Efficacy in Respiratory Tract Infections

Studies comparing short-course azithromycin therapy (typically 3 to 5 days) against longer courses of alternative antibiotics (up to 10 days) for upper respiratory tract infections (URTIs), such as acute otitis media and pharyngitis/tonsillitis, generally found comparable clinical outcomes. This suggests that the shorter course of azithromycin is sufficient for achieving a therapeutic response in many common bacterial infections.

Condition Typical Research Findings
Acute Otitis Media (Children) Comparable clinical outcomes to 7–10 day courses of other antibiotics.
Community-Acquired Pneumonia (CAP) Short courses (5 days) are often effective for mild-to-moderate CAP.

Focus on Chronic Conditions and Safety

Beyond its antibacterial use, azithromycin has been investigated for its potential anti-inflammatory and immunomodulatory properties, particularly in chronic respiratory diseases like asthma and COPD. However, its use in these non-standard indications is complex, and research findings may be conflicting or require further confirmation.

Safety studies continue to explore the rare but serious risk of cardiovascular events, specifically QTc prolongation, which has been found to be most pronounced in patients who already have a high baseline cardiovascular risk. Decisions regarding treatment duration and patient eligibility are constantly refined based on the need to balance clinical efficacy against the rising concern of antimicrobial resistance.

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Сумамед форте (FAQ)

Q: What is the active ingredient in Сумамед форте?

The active ingredient in Сумамед форте is Azithromycin (as Dihydrate). It belongs to a group of medicines known as macrolide antibiotics, specifically the azalide subclass. Official documents confirm that this drug works by inhibiting the growth and replication of susceptible bacteria.


Q: What kind of infections is Сумамед форте typically used for?

Official regulatory documents specify that this medicine is indicated for treating a variety of infections caused by susceptible bacteria. These typically include infections of the upper and lower respiratory tract (such as community-acquired pneumonia), as well as certain skin, ear, and throat infections.


Q: Why do doctors prescribe Сумамед форте for respiratory infections?

According to official product information, the medicine has a unique profile that allows it to achieve high concentrations in body tissues and remain effective for an extended period. This long half-life means the active substance is sustained in the body, which regulatory documents recognize as a feature leveraged for short-course therapy in respiratory infections.


Q: Why do some people take Сумамед форте for only three days?

Official documents describe the drug's extended half-life, which is the time it takes for the concentration of the medicine to reduce by half. This long half-life means the active substance remains in the body and tissues for several days after the final dose, allowing for a shorter overall treatment duration, such as a three-day course.


Q: How long does Сумамед форте stay in the body after the last dose?

Official pharmacokinetic data for azithromycin indicates that the medicine has a long terminal elimination half-life of approximately 68 hours. This pharmacological property is the reason why the medicine is administered over a short course but continues its activity in the body for a longer duration.


Q: Does Сумамед форте work against viruses?

Official regulatory information classifies this medicine strictly as an antibiotic. Antibiotics are specifically designed to eliminate or halt the growth of susceptible bacteria and are not effective against viruses, meaning it cannot treat viral infections like the common cold or flu.


Q: Are there different strengths of Сумамед форте available?

The active ingredient, azithromycin, is officially available in several different strengths (for example, 250 mg and 500 mg) for oral administration. The available strength may vary based on the specific formulation or the region where it is sold.


Q: How is the dose of Сумамед форте suspension calculated for a child?

For pediatric patients, the administration guidelines establish that the dose of the oral suspension is calculated based on the child's body weight (milligrams per kilogram). This method is established in administration guidelines to determine the appropriate amount of medicine based on body mass.


Q: Can this drug be taken without food?

Yes. Official instructions in the Dosage and Administration section state that the oral suspension can generally be taken with or without food. There are no specific food groups that official documentation lists as necessary to avoid when taking this medicine.


Q: What should I know about taking antacids and Сумамед форте together?

The official administration instruction is to separate intake from aluminum- or magnesium-containing antacids by at least one to two hours. This is because these antacids are documented to reduce the drug's peak serum concentration, requiring a separation of intake time.


Q: Does Сумамед форте interact with birth control pills?

Some regulatory documents advise that certain antibiotics, including macrolides, may theoretically reduce the effects of hormonal contraceptives (birth control pills). Official guidance advises that patients consult their healthcare provider regarding the need for potential precautionary measures.


Q: Can Сумамед форте be taken if I am on blood thinners?

Regulatory documents state that co-administration with oral anticoagulants, sometimes referred to as 'blood thinners,' may potentiate their effects. If co-administered, regulatory documents state that monitoring of prothrombin time may be required due to the potential for potentiating the effects of the anticoagulant.


Q: Does Сумамед форте interact with common pain relievers like paracetamol?

Official drug interaction lists typically do not specify an interaction between azithromycin and the active ingredient in paracetamol (acetaminophen). Regulatory documents do advise informing a healthcare provider about all medicines used.


Q: Does Сумамед форте interact with herbal supplements?

Regulatory documents include a general statement that all medicinal and herbal products used should be noted by a healthcare provider to check for potential interactions. This is standard guidance because some supplements can affect how prescription drugs work.


Q: Can I use Сумамед форте if I am allergic to penicillin?

Yes. Azithromycin is a macrolide antibiotic and is not chemically related to the penicillin class of antibiotics. Regulatory and medical sources confirm there is no documented structural cross-reactivity between the two classes.


Q: Can older people take Сумамед форте?

Use is generally established for adults, including older adults. However, regulatory labels identify older patients as having a potentially heightened risk of cardiac arrhythmia (irregular heartbeat) when taking this medicine, and note that caution may be necessary for patients in this population.


Q: Are there special restrictions for people with kidney problems using this medicine?

Regulatory guidance indicates that no dosage adjustment is generally required for patients with mild to moderate renal (kidney) impairment. However, caution is advised in official documents for patients with severe renal impairment.


Q: Can I use this medication if I have a history of certain electrolyte imbalances?

Caution is noted in regulatory documents for patients with medical conditions that predispose them to QT interval prolongation, including specific known electrolyte abnormalities (e.g., low potassium or magnesium). This is due to a potential impact on heart rhythm.


Q: Does the use of Сумамед форте lead to antibiotic resistance?

Official documents state that the use of this medicine, like all antibacterials, contributes to the potential development of drug-resistant bacteria if not used precisely as prescribed.


Q: Why is the full course of treatment important even if symptoms improve quickly?

Regulatory guidance on antibiotics specifies that completing the full prescribed course is intended to minimize the risk of bacterial recurrence and the development of drug resistance. Stopping the medicine prematurely or misusing it may increase these risks.


Q: What are the most commonly reported side effects of Сумамед форте?

The most frequently reported adverse reactions in official documents are gastrointestinal disorders. These include effects such as diarrhea, nausea, abdominal pain, and vomiting.


Q: Can Сумамед форте cause diarrhea?

Yes. Diarrhea is listed in official documentation as a Very Common side effect, meaning it is among the most frequently observed effects reported in studies.


Q: Is stomach pain a common issue with Сумамед форте?

Yes. Official regulatory information lists abdominal pain as a Very Common adverse reaction, confirming that it is one of the more frequently experienced effects.


Q: Is it common for people to experience changes in appetite with Сумамед форте?

Yes. Official documentation reports anorexia (loss of appetite) as a Common side effect, which may be experienced by up to 1 in 10 patients.


Q: Is it common to feel tired while taking Сумамед форте?

Official adverse reaction lists sometimes report fatigue or feeling tired as a possible, but less frequent, general disorder. Other central nervous system effects like dizziness and headache are reported more commonly.


Q: Is it normal if I vomit after taking the suspension?

Vomiting is officially listed as a Common side effect, meaning it may be experienced by up to 1 in 10 patients. As with any adverse effect, severe or persistent vomiting should be promptly noted for medical assessment.


Q: Is it normal to have a metallic taste after taking Сумамед форте suspension?

Official documentation lists a change in the sense of taste (medically termed dysgeusia) as a possible adverse reaction. This change in taste can sometimes be described as a metallic or unpleasant taste.


Q: Can this medicine affect the heart rhythm?

Yes. Regulatory documents note that the medicine is associated with a risk of QT interval prolongation (an electrical change in the heart's rhythm), which has the potential to cause a serious irregular heart rhythm (arrhythmia).


Q: What does the official patient leaflet say about driving while using Сумамед форте?

Regulatory documents contain warnings that patients may experience side effects such as dizziness or convulsions. These effects could potentially impair the ability to drive or safely operate machinery.


Q: Is Сумамед форте known to cause sun sensitivity?

Official documentation lists photosensitivity (increased sensitivity to sunlight) as a possible, though less common, adverse reaction. Due to this documented potential, minimizing exposure to intense sunlight and artificial UV light is a common precautionary measure.


Q: Is it true that Сумамед форте has anti-inflammatory properties?

Scientific studies have examined the molecule's ability to modulate immune cell signaling and reduce inflammation, which is separate from its antibacterial properties. However, this is not listed as an official indication for the use of the medicine.


Q: What are the rules about using Сумамед форте while breastfeeding?

Azithromycin is excreted into human breast milk. Official documents indicate that use during breastfeeding is permitted only if the clinical benefit to the mother is considered to outweigh the potential risk to the child.

Advertisements

How should Сумамед форте be stored and disposed of?

How to Store and Dispose of Сумамед форте?

Official guidelines define the strict conditions required to maintain the stability of Azithromycin Oral Suspension.

Official Storage Requirements

Item Mandatory Rule
Powder Storage Temperature Store the unmixed powder at controlled room temperature, typically below 30°C (86°F).
Suspension Storage Store the prepared liquid suspension at room temperature (e.g., below 25°C or 77°F).
Handling Prohibition Do not refrigerate or freeze the liquid suspension.
Container Rule Keep the medicine in its original container, tightly closed, and protected from excess moisture.
Stability Period The prepared suspension must be discarded after its labeled period (e.g., 5 to 10 days), even if medicine remains.
Child Safety Store the medicine in a secure location, out of the sight and reach of children.

Disposal Instructions

Disposal must follow official regulatory protocols to prevent environmental contamination. Unused or expired medication should not be thrown into household trash or poured down a sink. Instead, utilize a designated drug take-back program or follow the official instructions provided by a pharmacist for mixing the product with an undesirable substance before discarding.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Сумамед форте found in:

A-Z Index: